Recurrent/metastatic head and neck cancer

Clinical trials for Recurrent/metastatic head and neck cancer explained in plain language.

Never miss a new study

Get alerted when new Recurrent/metastatic head and neck cancer trials appear

Sign up with your email to follow new studies for Recurrent/metastatic head and neck cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New antibody injection takes aim at Hard-to-Treat head and neck cancer

Disease control Not yet recruiting

This study tests a new drug called TQB2922, given as a shot under the skin, for people with head and neck cancer that has come back or spread. The drug is a special antibody that targets two proteins (EGFR and c-Met) involved in cancer growth. The trial has two parts: first, find…

Matched conditions: RECURRENT/METASTATIC HEAD AND NECK CANCER

Phase 1/2 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC

Recurrent/metastatic head and neck cancer

Get alerted when new Recurrent/metastatic head and neck cancer trials appear

New antibody injection takes aim at Hard-to-Treat head and neck cancer